Post-IPO Equity - Innovent Biologics - Aug 4, 2022 Funding Round Profile - Cointime

Bitcoin $93,161.98 -2.92%
Ethereum $3,310.69 -6.02%
BNB $614.72 -5.46%
Optimism $2.17 -8.26%
Arbitrum $0.86 -9.23%
Solana $228.54 -6.61%
Polygon $0.52 -11.16%
Cosmos $7.79 -6.36%
Avalanche $41.42 -5.07%

Bitcoin $93,161.98 -2.92%
Ethereum $3,310.69 -6.02%
BNB $614.72 -5.46%
Optimism $2.17 -8.26%
Arbitrum $0.86 -9.23%
Solana $228.54 -6.61%
Polygon $0.52 -11.16%
Cosmos $7.79 -6.36%
Avalanche $41.42 -5.07%

Innovent Biologics

company

Funding Round

Post-IPO Equity

Money Raised

$ 2.42B

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Sanofi	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Nov 29, 2016	Series D	$ 260M	Milestone	Detail
Nov 16, 2012	Series B	$ 30M	Lilly Asia Ventures	Detail
Jan 22, 2015	Series C	$ 115M	Lilly Asia Ventures	Detail
Apr 27, 2018	Series E	$ 150M	Lilly Asia Ventures	Detail